Imatinib vs Rituximab
Imatinib vs Rituximab: Overview
This comparison examines the pharmacological differences between Imatinib and Rituximab.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Imatinib β 18 hours; Rituximab β 22 days.
Chemical Properties
Molecular Formula: Imatinib β C29H31N7O.
Molecular Weight: Imatinib β 493.6030 g/mol.
Type: Imatinib β Small molecule; Rituximab β Antibody.